Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Grant/Award of 37,653 OBX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Obsidian Therapeutics, Inc. (OBX) | Grant/Award | 37,653 | n/a |
| Jun 9, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Jun 6, 2025 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| May 31, 2024 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Jun 9, 2023 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Jun 10, 2022 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 24,000 | n/a |
| Jan 6, 2021 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/Award | 250,000 | n/a |
| Jun 2, 2020 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Tax Withholding | 1,894 | $62.7K |
| May 5, 2020 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Tax Withholding | 1,894 | $60.6K |
| Apr 3, 2020 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Tax Withholding | 1,494 | $41.7K |